Lifecore Biomedical, Inc. De (LFCR) Free Cash Flow (2010 - 2025)

Lifecore Biomedical's Free Cash Flow history runs 16 years deep, the most recent figure standing at $3.2 million for Q2 2025.

• In Q2 2025, Free Cash Flow fell 45.86% year-over-year to $3.2 million; the TTM figure through May 2025 stood at -$13.6 million (up 24.9% YoY), while the FY2025 annual figure was -$13.6 million, up 24.9% from the prior year.
• Free Cash Flow was $3.2 million for Q2 2025 at Lifecore Biomedical, up from -$4.3 million in the prior quarter.
• In the past five years, Free Cash Flow ranged from a high of $6.0 million in Q2 2024 to a low of -$18.8 million in Q1 2023.
• Historically, Free Cash Flow has averaged -$5.6 million across 5 years, with a median of -$5.7 million in 2021.
• The sharpest annual moves came in 2022 and 2024: Free Cash Flow tumbled 387.47% in 2022, then jumped 163.62% in 2024.
• A 5-year view of Free Cash Flow shows it stood at $2.5 million in 2021, then sank by 387.47% to -$7.3 million in 2022, then soared by 59.38% to -$3.0 million in 2023, then slumped by 188.6% to -$8.6 million in 2024, then soared by 137.88% to $3.2 million in 2025.
• The last three Free Cash Flow figures came in at $3.2 million (Q2 2025), -$4.3 million (Q1 2025), and -$8.6 million (Q4 2024), per Business Quant data.